Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Jul 15, 2022; 14(7): 1265-1280
Published online Jul 15, 2022. doi: 10.4251/wjgo.v14.i7.1265
Published online Jul 15, 2022. doi: 10.4251/wjgo.v14.i7.1265
Figure 5 Expression levels analysis of decorin, dermatopontin, and SRY-box transcription factor 9 in human liver tissues.
A-C: The percentage of positive area of decorin (DCN) , dermatopontin (DPT) and SRY-box transcription factor 9 (SOX9) among normal (n = 5 or 7), S0 (n = 3 or 4), S1-S2 (n = 10 or 12), S3-S4 (n = 8, 9 or 11) and hepatocellular carcinoma (HCC) (n = 11, 12 or 14) groups were counted; D-F: The percentage of positive area of DCN , DPT and SOX9 in normal (n = 5 or 7), liver fibrosis (n = 22, 23 or 26) and HCC (n = 11, 12 or 14) groups were counted. All data were presented as mean ± SE.One-way ANOVA with multiple comparisons and Tukey’s post-test were performed, aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Li Y, Yuan SL, Yin JY, Yang K, Zhou XG, Xie W, Wang Q. Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis. World J Gastrointest Oncol 2022; 14(7): 1265-1280
- URL: https://www.wjgnet.com/1948-5204/full/v14/i7/1265.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i7.1265